繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Teradyne股价暴跌20%,公司发现SemiTest业务波动

2025-03-11 22:53

Shares of Teradyne (NASDAQ:TER) tumbled about 20% on Tuesday after the company updated its business guidance.

The company said it sees short-term volatility mainly in its SemiTest business. Teradyne, which makes and sells automated test systems and robotics products, added that there is new uncertainty around tariffs and trade restrictions.

However, the company noted in its Financial Analyst Day presentation on Tuesday that there are no cancellations, but some push outs and capital reviews.

President and CEO Greg Smith had said during the company's fiscal fourth quarter earnings call that, while the Semi Test business was strong in 2024, Teradyne's other product test businesses which include our System Test and Wireless Test operating segments continued to be impacted by weak end market conditions. Within our product test businesses, we saw some programs push out from 2024 into 2025 but scored key program wins that we expect to drive healthy growth in 2025."

Chip stocks had fallen on Monday amid fears of a potential downturn in the U.S. economy in light of recent tariff decisions, even as the Trump administration looked to deflect these concerns.

Teradyne said it expects no impact to its fiscal first quarter 2025 guidance. During its fourth quarter results in January, the company noted that it expects first quarter adjusted EPS to be in the range from $0.58 to $0.68, with a midpoint of $0.63, compared to consensus estimate of $0.62. The company expects revenue to be between $660M and $700M, with a midpoint of $680M versus the consensus estimate of $681.07M.

The company expects fiscal second quarter revenue to be flat to 10% down versus the first quarter revenue. 

In addition, Teradyne said it expects fiscal year 2025 growth to be between 5% and 10% relative to fiscal year 2024.

The company said its 2026 guidance remains unchanged from January. The company noted that revenue and EPS are trending toward the low end of the previous 2026 earnings model.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。